Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm Phase (II) Study on MR-based Hypofractionated Adaptive Image-guided Radiation Therapy for Prostate Cancer

NCT03880851 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03880851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03880851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm Phase (II) Study on MR-based Hypofractionated Adaptive Image-guided Radiation Therapy for Prostate Cancer
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Unknown status
Start date
January 23, 2019
Completion date
January 31, 2024
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer